Stuff like this does make sense from his T2 Diabetes perspective. Until GPs are better educated about ME there’s always going to be a high risk that they will try to deploy this type of approach with people with ME that’s already the status quo I don’t think this particular article will make the...
Except he has 500k twitter followers so it may be worth one of his academic peers approaching him just in case he is more open minded than that
Dunno if anyone on here has a link in to any of the Harvard Group?
Yes I could be reading too much into it. It’s just the Kelland Reuter’s article whole point was the Cochrane issue so it struck me that the only new point in the whole thing was that one about Cochrane so possibly using similar tactics. Would be great if it backfired
I don’t think it’s trying too hard to argue anything it’s just rehashed old material with that snippet about the Cochrane editor backtracking on the previous guy’s decision - which in my opinion is the whole point of it.
so Presumably the whole purpose of the article is to get out that point about the Cochrane review and the new editor overturning the decision- Sharpe must think by making it known she’s going to overturn it it makes it harder for her to reconsider that.......maybe she isn’t fully on board yet
May be a ridiculous question but If the purine metabolite is reduced does that mean there’s also more purine still going round in the system? On my postage stamp understanding it is the purine that causes the problems & pain in gout. Could this be causing pain in ME.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.